Crawley, United Kingdom

Roushanak Rahmat

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Elekta, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roushanak Rahmat: Innovator in Adaptive Radiotherapy

Introduction

Roushanak Rahmat is a notable inventor based in Crawley, GB. He has made significant contributions to the field of radiotherapy through his innovative techniques. His work focuses on enhancing the accuracy and effectiveness of radiotherapy treatments.

Latest Patents

Roushanak Rahmat holds 1 patent for his invention titled "Techniques for adaptive radiotherapy based on CBCT projection correction and reconstruction." This patent discloses systems and methods for processing cone beam computed tomography (CBCT) image data in connection with radiotherapy planning and treatments. The operations outlined in the patent include obtaining newly captured CBCT projections, reconstructing quantitative CBCT images, identifying anatomical changes in patients, and modifying treatment plans based on these changes.

Career Highlights

Roushanak Rahmat is currently employed at Elekta, Inc., a company known for its advanced medical technology solutions. His role involves applying his expertise in radiotherapy to improve patient outcomes. His innovative approach has positioned him as a key figure in the development of adaptive radiotherapy techniques.

Collaborations

Roushanak has collaborated with notable colleagues such as Jonathan Mason and Joseph Stancanello. These collaborations have further enhanced the research and development efforts in the field of radiotherapy.

Conclusion

Roushanak Rahmat's contributions to adaptive radiotherapy demonstrate his commitment to advancing medical technology. His innovative techniques are paving the way for more effective treatments in the field of radiotherapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…